Mesoblast’s Phase 3 Trial of Revascor in Advanced Chronic Heart Failure Surpasses the Number of Primary Endpoint Events for Trial Completion

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement